In-body viral vector wipes out MS-driving immune cells
A first-in-human proof of concept delivered an engineered virus directly into patients, instructing their immune system to locate and eliminate the auto-reactive cells driving multiple sclerosis — no lab dish required.
- Viral vector reprograms T-cells inside the patient rather than ex vivo in a laboratory
- Approach selectively eliminates pathogenic immune cells while sparing healthy function
- Nature published the finding; represents a new class of in vivo cell engineering therapy